학술논문

Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma
Document Type
Report
Author
Johnson, Douglas B.Atkins, Michael B.Hennessy, CassandraWise-Draper, TrishaHeilman, HannahAwosika, JoyBakouny, ZiadLabaki, ChrisSaliby, Renee MariaHwang, ClaraSingh, Sunny R. K.Balanchivadze, NinoFriese, Christopher R.Fecher, Leslie A.Yoon, James J.Hayes-Lattin, BrandonBilen, Mehmet A.Castellano, Cecilia A.Lyman, Gary H.Tachiki, LisaShah, Sumit A.Glover, Michael J.Flora, Daniel B.Wulff-Burchfield, ElizabethKasi, AnupAbbasi, Saqib H.Farmakiotis, DimitriosViera, KendraKlein, Elizabeth J.Weissman, Lisa B.Jani, ChinmayPuc, MatthewFahey, Catherine C.Reuben, Daniel Y.Mishra, SanjayBeeghly-Fadiel, AliciaFrench, BenjaminWarner, Jeremy L.Reid, Sonya A.Brown, Alaina J.Cheng, AlexCroessmann, SarahDavis, Elizabeth J.Enriquez, Kyle T.Gillaspie, Erin A.Hausrath, DanielLi, XuanyiSlosky, David A.Solorzano, Carmen C.Tucker, Matthew D.Vega-Luna, KarenWang, Lucy L.Wise-Draper, Trisha M.Ahmad, Syed A.Grover, PunitaGulati, ShuchiKharofa, JordanLatif, TahirMarcum, MichelleSohal, Davendra P. S.Zamulko, OlgaChoueiri, Toni K.Connors, Jean M.Demetri, George D.Duma, NarjustFreeman, Dory A.Giordano, AntonioMorgans, Alicia K.Nohria, AnjuSaliby, Renee-MariaSchmidt, Andrew L.Van Allen, Eliezer M.Xu, WenxinZon, Rebecca L.Gadgeel, Shirish M.Tejwani, SheelaBoldt, AnneCohen, Aaron M.McWeeney, ShannonNemecek, Eneida R.Williamson, Staci P.Ravindranathan, DeepakGraber, Jerome J.Grivas, PetrosHawley, Jessica E.Loggers, Elizabeth T.Lynch, Ryan C.Nakasone, Elizabeth S.Schweizer, Michael T.Vinayak, ShavetaWagner, Michael J.Yeh, AlbertCabebe, Elwyn C.Jha, AlokkumarKhaki, Ali RazaSchapira, LidiaWu, Julie Tsu-YuKloecker, GoetzLogan, Barbara B.Mandapakala, ChaitanyaRock, Crosby D.Arvanitis, PanosEgan, Pamela C.Khan, HinaOlszewski, Adam J.Vieira, KendraWeissmann, Lisa B.Bhatt, Padmanabh S.Mariano, Melissa G.Thomson, Carey C.Carducci, Theresa M.Goldsmith, Karen J.Van Loon, SusanAlexander, MariamMatar, SaraMushtaq, SarahStockerl-Goldstein, Keith E.Butt, OmarFiala, Mark A.Henderson, Jeffrey P.Monahan, Ryan S.Zhou, Alice Y.Lammers, Philip E.Revankar, Sanjay G.Del Prete, Salvatore A.Bar, Michael H.Gulati, Anthony P.Lo, K. M. SteveRose, Suzanne J.Stratton, JamieWeinstein, Paul L.Gupta, ShilpaPennell, Nathan A.Ahluwalia, Manmeet S.Dawsey, Scott J.Lemmon, Christopher A.Nizam, AmandaSharifi, NimaHoppenot, ClaireLi, AngHalabi, SusanDzimitrowicz, HannahZhang, TianGoyal, SharadHuynh-Le, Minh-PhuongYu, Peter PaulClement, Jessica M.Daher, AhmadDailey, Mark E.Elias, RawadJayaraj, AshaHsu, EmilyMenendez, Alvaro G.Serrano, Oscar K.Accordino, Melissa K.Bhutani, DivayaHershman, DawnIngham, Matthew A.Schwartz, Gary K.Bernicker, Eric H.Deeken, John F.Shafer, DanielleRuíz-García, ErikaRamirez, AnaVilar-Compte, DianaLewis, Mark A.Rhodes, Terence D.Gill, David M.Low, Clarke A.Mashru, Sandeep H.Mansoor, Abdul-HaiLewis, Grant C.Smith, Stephanie J.Zaren, Howard A.Nagaraj, GayathriAkhtari, MojtabaCastillo, Dan R.Lau, EricReeves, Mark E.Berg, StephanieKnox, NatalieO'Connor, Timothy E.Durbin, Eric B.Kulkarni, Amit A.Nelson, Heather H.Sachs, ZoharRosovsky, Rachel P.Reynolds, Kerry L.Bardia, AdityaBoland, GenevieveGainor, Justin F.Zubiri, LeyreHalfdanarson, Thorvardur R.Bekaii-Saab, Tanios S.Desai, AakashRiaz, Irbaz B.Shah, SurbhiSmith, Katherine E.Williams, ColtBouganim, NathanielElkrief, AriellePanasci, JustinVinh, Donald C.Riely, Gregory J.Belenkaya, RimmaPhilip, JohnFaller, BryanMcKay, Rana R.Ajmera, ArchanaBrouha, Sharon S.Choi, SharonHsiao, AlbertKligerman, SethNonato, Taylor K.Blau, Erin G. Reid SibelJhawar, Sachin R.Addison, DanielChen, James L.Gatti-Mays, Margaret E.Karivedu, VidhyaPalmer, Joshua D.Stover, Daniel G.Wall, SarahWilliams, Nicole O.Joshi, MonikaPolimera, Hyma V.Pomerantz, Lauren D.Rovito, Marc A.Griffiths, Elizabeth A.Advani, Pragati G.Puzanov, IgorJabbour, Salma K.Misdary, Christian F.Shah, Mansi R.Batist, GeraldCook, ErinDutra, Miriam SantosFerrario, CristianoMiller, Wilson H.Bashir, BabarMcNair, ChristopherMahmood, Sana Z.Mico, VasilRivera, Andrea VergheseEdwin, Natasha C.Smits, MelissaDoroshow, Deborah B.Galsky, Matthew D.Wotman, MichaelFazio, AlysonFu, Julie C.Huber, Kathryn E.Sueyoshi, Mark H.Koshkin, Vadim S.Borno, Hala T.Kwon, Daniel H.Small, Eric J.Zhang, SylviaRubinstein, Samuel M.Wood, William A.Andermann, Tessa M.Jensen, ChristopherBowles, Daniel W.Geiger, Christoper L.Feldman, Lawrence E.Hoskins, Kent F.Gantt, GeraldLiu, Li C.Khan, MahirNguyen, Ryan H.Pasquinelli, MarySchwartz, CandiceVenepalli, Neeta K.Mavromatis, Blanche H.Bijjula, Ragneel R.Zaman, Qamar U.Aboulafiam, David M.Schroeder, Brett A.Topaloglu, UmitAlimohamed, Saif I.Moore, Joan K.Peddi, PrakashRosen, Lane R.McCollough, Briana BarrowHafez, NavidHerbst, RoyLoRusso, PatriciaLustberg, Maryam B.Masters, TylerStratton, Catherine
Source
BMC Cancer. March 23, 2023, Vol. 23 Issue 1
Subject
United States
Language
English
ISSN
1471-2407
Abstract
Introduction COVID-19 particularly impacted patients with co-morbid conditions, including cancer. Patients with melanoma have not been specifically studied in large numbers. Here, we sought to identify factors that associated with COVID-19 severity among patients with melanoma, particularly assessing outcomes of patients on active targeted or immune therapy. Methods Using the COVID-19 and Cancer Consortium (CCC19) registry, we identified 307 patients with melanoma diagnosed with COVID-19. We used multivariable models to assess demographic, cancer-related, and treatment-related factors associated with COVID-19 severity on a 6-level ordinal severity scale. We assessed whether treatment was associated with increased cardiac or pulmonary dysfunction among hospitalized patients and assessed mortality among patients with a history of melanoma compared with other cancer survivors. Results Of 307 patients, 52 received immunotherapy (17%), and 32 targeted therapy (10%) in the previous 3 months. Using multivariable analyses, these treatments were not associated with COVID-19 severity (immunotherapy OR 0.51, 95% CI 0.19 - 1.39; targeted therapy OR 1.89, 95% CI 0.64 - 5.55). Among hospitalized patients, no signals of increased cardiac or pulmonary organ dysfunction, as measured by troponin, brain natriuretic peptide, and oxygenation were noted. Patients with a history of melanoma had similar 90-day mortality compared with other cancer survivors (OR 1.21, 95% CI 0.62 - 2.35). Conclusions Melanoma therapies did not appear to be associated with increased severity of COVID-19 or worsening organ dysfunction. Patients with history of melanoma had similar 90-day survival following COVID-19 compared with other cancer survivors. Keywords: COVID-19, Melanoma, Immune therapy, Targeted therapy, Cancer
Author(s): Douglas B. Johnson[sup.1] , Michael B. Atkins[sup.2] , Cassandra Hennessy[sup.1] , Trisha Wise-Draper[sup.3] , Hannah Heilman[sup.3] , Joy Awosika[sup.3] , Ziad Bakouny[sup.4] , Chris Labaki[sup.4] , Renee Maria Saliby[sup.4] [...]